This report describes a usually mild syndrome, dubbed LICATS, affecting about three-quarters of CAR T-cell recipients.

A new study finds that specific B-cell subsets at diagnosis may help predict remission in early rheumatoid arthritis, ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the TRANSFORM trial of lisocabtagene maraleucel in B-cell ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

According to an affidavit, Clemente Lopez Jr. admitted to "allowing these types of assaults" in recent months.

Genocury Biotech announces positive results from noval in vivo CD19 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma: Shenzhen, China Friday, May 2, 2025, 15:00 ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Cultivated meat is an emerging field of food technology, however, to make it viable, it is important to learn how to optimize ...